January 30, 2026

Mind + Machine: How 2026 Brands Will Win the Future of Pharma Marketing 

In our recent webinar, leaders across strategy, creative, technology and omnichannel disciplines explored one essential question: How do 2026 brands win in a rapidly transforming healthcare ecosystem? 

The answer? By embracing a new era where AI, enablement, omnichannel orchestration and brand trust converge to redefine the very job of marketing. Here’s a high-level look at the themes that defined the conversation: 

The Healthcare Landscape Is Being Rewritten by AI 

Across every part of our healthcare system – diagnosis, monitoring, treatment decisions, patient behavior – AI is an influential stakeholder. It’s not simply adding efficiencies, but rather reshaping how care is made, delivered and understood. 

This shift is happening alongside broad sociocultural changes: 

  • Patients are more informed but also more vulnerable to misinformation. 
  • HCPs hold less influence as telemedicine and algorithmic tools rise. 
  • Insurers, employers and governments play a larger role in treatment pathways. 

Together, these forces are creating a more complex, less predictable decision landscape; one that brands must now navigate with greater agility. 

Enablement Is Emerging as a New Competitive Advantage 

A major theme was the rise of operational complexity and the growing burden placed on physicians, staff and patients. With clinical differentiation narrowing, the brands that win will be those that remove friction from the care experience. 

This includes making it easier to start therapy, navigate access, manage logistics such as refills and follow-ups and support patients between visits. The perspective shared made clear that the modern brand is no longer defined solely by clinical benefit. The therapeutic experience itself is becoming a differentiator. 

Omnichannel Is Evolving Into an “Experience Operating Model” 

Omnichannel has matured far beyond channel planning. Instead, it’s becoming a continuous, adaptive system that responds to individual needs, signals and behaviors across all touchpoints. 

Key drivers of this evolution include: 

  • An explosion of micro‑experiences across digital, physical and connected environments 
  • A surge in data and signals powering personalization 
  • Rising customer expectations shaped by retail, streaming and social platforms 

The future, Dan Gandor, EVP and Head of Omnichannel & Digital Transformation, shared, is not about producing more content or launching more campaigns. Brands instead need to focus on designing integrated, intelligent experiences that guide customers seamlessly from first awareness to ongoing support.

Brands Must Earn Trusted Attention in a Low‑Trust World 

With content production becoming nearly instantaneous through AI, the real scarcity is attention. In a world where trust in institutions is eroding, audiences look to individuals, not logos, to guide their understanding. 

This is not to say that big campaigns don’t still matter, but small, consistent, recognizable moments are what build real connection in this trust economy. Brands need creative systems flexible enough to show up meaningfully across countless touchpoints. 

The Path Forward: Mind + Machine, Together 

While the topics spanned AI, experience design, creative evolution and commercial operations, the message was unified: 2026 will reward brands that blend strategic imagination with intelligent, AI‑powered execution. 

By pairing human insight with technological acceleration, pharma leaders can build brands that not only keep pace with change but shape it. 

Complete the form below to access the full webinar recording.   

Catch the Replay

Submit Your Details to Access the Content